Accurate cancer diagnosis and staging are essential for developing an effective treatment plan. Modern medical imaging helps doctors understand the location of a tumour, evaluate whether cancer has spread, and monitor changes during treatment. Positron emission tomography combined with computed tomography, commonly known as PET CT, is an advanced diagnostic technique that provides both metabolic and anatomical information in a single examination.

Patients searching for a PET CT scan hospital India can explore specialized medical centres offering advanced imaging facilities and professional diagnostic services. These centres may have nuclear medicine specialists, radiologists, and trained technical staff who work together to support accurate image interpretation. The need for PET CT imaging depends on the patient's symptoms, suspected diagnosis, cancer type, and recommendations from the treating doctor.
A PET CT scan combines two imaging techniques: positron emission tomography (PET) and computed tomography (CT). PET evaluates metabolic activity in body tissues, while CT produces detailed images of internal organs and anatomical structures.
For many cancer examinations, doctors use a radioactive tracer called fluorodeoxyglucose (FDG). This tracer behaves similarly to glucose and accumulates in tissues according to their metabolic activity. Some cancer cells use more glucose than surrounding tissues, making certain abnormalities visible during scanning.
However, increased tracer uptake does not always indicate cancer. Infection, inflammation, and normal physiological processes can also produce increased uptake. Specialists interpret the findings alongside medical history, physical examination, biopsy results, and other diagnostic tests.
A cancer staging PET CT scan can help doctors evaluate the extent of selected cancers and identify areas that may require further investigation. Staging describes the size and location of the primary tumour and whether the disease has spread to nearby lymph nodes or distant organs.
PET CT may be recommended for staging certain lymphomas, lung cancers, and other malignancies when appropriate. The results can help clinicians determine whether additional treatment is needed and support decisions about surgery, radiation therapy, chemotherapy, or systemic treatments.
The scan may also help assess suspected recurrence after treatment or evaluate how a cancer responds to therapy. Nevertheless, PET CT is not necessary for every cancer type or every patient. The treating specialist determines whether the examination is appropriate for the particular clinical situation.
PET CT findings provide useful information about areas of increased metabolic activity and their anatomical location. When combined with biopsy reports and other investigations, these findings can help specialists understand the disease more comprehensively.
In selected cases, imaging may help identify suspicious sites for biopsy, support radiation treatment planning, or assess whether cancer has spread beyond the original location. Follow-up scans may also help evaluate treatment response.
However, PET CT results do not independently establish every cancer diagnosis. Some tumours show limited tracer uptake, and certain abnormalities require confirmation through additional imaging or tissue sampling.
The process usually begins with preparation instructions from the imaging centre. Patients may be asked to fast for several hours and avoid strenuous exercise before the examination. People with diabetes should discuss blood glucose management and medication instructions with the healthcare team.
A small amount of radioactive tracer is injected into a vein. Patients generally rest quietly for approximately 45–60 minutes while the tracer distributes throughout the body.
During the scan, the patient lies on a motorized table that moves through the scanner. Image acquisition commonly takes around 20–40 minutes, although the timing varies by protocol. The procedure is generally painless.
A qualified specialist interprets the images and sends the report to the referring doctor.
PET CT involves exposure to ionizing radiation from the tracer and CT component. The scan should be performed when its expected diagnostic benefits justify the exposure. Patients should inform the medical team about pregnancy, breastfeeding, diabetes, medications, and relevant health conditions.
Following preparation instructions can improve image quality and help reduce the likelihood of needing another examination.
When selecting a hospital, consider the availability of suitable imaging equipment, qualified nuclear medicine specialists, radiation safety practices, reporting expertise, and coordination with the oncology team. Patients may also ask about appointment availability, preparation requirements, report timelines, and examination costs.
PET CT imaging can play an important role in evaluating selected cancers, determining disease extent, and monitoring treatment response. Consulting an experienced oncology team helps ensure that the scan is appropriate and that its findings are interpreted in the context of the patient's complete medical assessment.